Atlas Trials

BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer

Clinical trial NCT03627390 · COMPLETED

Trial details

NCT number
NCT03627390
Sponsor
Meabco A/S
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic CancerUnresectable Pancreatic Cancer
Start date
2014-12-19
Primary completion
2016-03-04
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.